 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
| . |  |
. |
British drugs giant GSK says profits soar
London (AFP) Oct 28, 2009 British drugs group GlaxoSmithKline, maker of swine flu vaccine Pandemrix, said Wednesday that net profits surged 30 percent in the third quarter, aided by the weak pound and emerging markets. The group forecast "further improvement" and "significant sales" in the fourth quarter due to influenza products, as the world's governments prepare for mass vaccination programmes to prevent further spread of swine flu. GSK said in a results statement that net profit surged to 1.335 billion pounds (1.472 billion euros, 2.177 billion dollars) in the three months to September, compared with the same portion of 2008. "We are seeing direct evidence of success in our strategy to grow and diversify the business away from 'white pill/western markets'," said chief executive Andrew Witty in the earnings release. Emerging market sales grew 25 percent in the third quarter and Japanese sales soared 19 percent. Sales of consumer healthcare products meanwhile increased by eight percent. On the downside, US sales sank 12 percent owing to intense competition from makers of generic drugs. "Our third quarter performance reinforces our expectations of an improved performance for GSK in the second half of 2009," added Witty. "In the fourth quarter, I expect further improvement including significant sales generated from our influenza products." Revenues meanwhile increased by 15 percent to 6.76 billion pounds in the reporting period. Stripping out the effect of exchange rates, however, revenues grew by three percent. GSK currently has orders for 440 million doses of its swine flu vaccine, Pandemrix, ahead of the northern hemisphere's winter that could bring a second wave of the virus. Earlier this month, the European Commission cleared Pandemrix and another vaccine, Focetria, for distribution in Europe. Focetria is produced by Swiss firm Novartis. In late afternoon deals on Wednesday, GSK shares dipped 1.03 percent to 1,243.50 pence on London's FTSE 100 index of leading companies, which was down 2.35 percent at 5,078.75 points. Share This Article With Planet Earth
Related Links Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola
Russia policies slammed at HIV conferenceMoscow (AFP) Oct 28, 2009 Russia came under fire from international AIDS campaigners on Wednesday for refusing to provide drug users with drug substitution therapy to stem a spreading HIV epidemic. Russia's chief medical official Gennady Onishchenko told a major AIDS conference that Moscow opposed providing methadone -- a synthetic drug that is not injected -- to heroin users. He said that Russia preferred to ... read more |
|
|
| The content herein, unless otherwise known to be public domain, are Copyright 1995-2009 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |
del.icio.us
Digg
Reddit
YahooMyWeb
Google
Facebook